NASDAQ:KYMR | Cash Flow Statement | Kymera Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2019-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$61.21M
2026-03-31-$69.23M$2.02M-$88.84M$434,000.00-$142.84M$18.77M
2025-12-31-$86.98M$2.03M-$66.75M$106,000.00-$394.4M$705.22M
2025-09-30-$82.18M
2025-06-30-$76.61M
2025-03-31-$65.58M$2.05M-$79.15M$467,000.00$48.62M$258,000.00
2024-12-31-$70.75M$1.99M-$61.78M$936,000.00$68.57M$2.77M
2024-09-30-$62.49M
2024-06-30-$42.06M
2024-03-31-$48.56M$1.46M-$39.59M$7.4M-$330.61M$353.76M
2023-12-31-$14.37M$891,000.00$8.05M$11.63M$18.95M$1.93M
2023-09-30-$52.87M
2023-06-30-$38.8M
2023-03-31-$40.93M$879,000.00-$43.97M$4.01M$24.58M$1.16M
2022-12-31-$34.87M$818,000.00-$39.54M$373,000.00-$49.67M$1.95M
2022-09-30-$43M
2022-06-30-$40.26M
2022-03-31-$36.68M$687,000.00-$40.3M$482,000.00$25.86M$185,000.00
2021-12-31-$33.9M$689,000.00-$38.35M$501,000.00-$68.02M$2.05M
2021-09-30-$28.58M
2021-06-30-$24.66M
2021-03-31-$13.08M$485,000.00-$22.82M$164,000.00$44.32M$595,000.00
2020-12-31-$12.69M$497,000.00-$20.07M$1.44M-$3.99M$270,000.00
2020-09-30-$7.99M
2020-06-30-$13.99M
2020-03-31-$10.93M$387,000.00-$12.06M$1.4M-$37.4M$93.12M
2019-12-31-$11.51M$361,000.00-$10.8M$199,000.00$61.96M$21.09M
2019-09-30-$11.42M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$311.35M$8.31M-$232.89M$1.45M-$521.06M$990.71M
2024-12-31-$223.86M$7.37M-$194.5M$12.84M-$404.08M$608.85M
2023-12-31-$146.96M$3.57M-$102.83M$34.48M$139.89M$4.19M
2022-12-31-$154.81M$2.98M-$153.09M$2.84M$20.52M$153M
2021-12-31-$100.22M$2.4M-$128.95M$1.6M-$99.84M$250.28M
2020-12-31-$45.59M$1.76M$88.13M$9.1M-$422.59M$289.26M
2019-12-31-$41.25M$825,000.00$17.91M$532,000.00-$16.49M$34.91M